Electromed, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Electromed, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 87.84K shares, a 5249.33% increase year-over-year.
- Electromed, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 5.34K shares.
- Electromed, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 7.10K shares.
- Electromed, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 14.30K shares.
- Electromed, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2026 was 114.58K shares, a 34.96% increase from fiscal 2025.
- Electromed, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 84.89K shares, a 50.04% increase from fiscal 2024.
- Electromed, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 56.58K shares.
- Electromed, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2015 was 0.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 87.84K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-25 | 114.58K shares 10-K · filed 2026-08-25 |
| 2026-03-31 | 5.34K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-12 | 28.38K shares derived: sum of 4 quarters · filed 2026-08-25 |
| 2025-12-31 | 7.10K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-10 | |
| 2025-09-30 | 14.30K shares 10-Q · filed 2025-11-12 | |
| 2025-06-30 | 1.64K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-25 | 84.89K shares 10-K · filed 2026-08-25 |
| 2024-06-30 | 56.58K shares 10-K · filed 2025-08-26 | |
| 2023-03-31 | 42.44K shares 10-Q · filed 2024-05-07 | |
| 2022-12-31 | 3.10K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-14 | |
| 2022-09-30 | 20.00K shares 10-Q · filed 2022-11-08 | |
| 2022-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-10 | |
| 2021-12-31 | 3.33K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-08 | |
| 2021-09-30 | 25.33K shares 10-Q · filed 2021-11-09 | |
| 2015-06-30 | 0.00 shares 10-K · filed 2015-09-15 | |
| 2014-06-30 | 0.00 shares 10-K · filed 2015-09-15 | |
| 2013-06-30 | 0.00 shares 10-K · filed 2014-09-23 | |
| 2012-06-30 | 12.00K shares 10-K · filed 2013-09-25 | |
| 2011-06-30 | 12.00K shares 10-K · filed 2012-09-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EDAP TMS SA (FOCL) | $0.171B | ||
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B |